SBIR/STTR Recipient

Scribe Therapeutics

Brief Description

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders. The molecular engineering company was spun out of discoveries in the lab of UC Berkeley Professor of Biochemistry, Biophysics and Structural Biology and Nobel Laureate Jennifer Doudna. Doudna co-founded Scribe with company CEO Benjamin Oakes, who received a PhD in Molecular and Cellular Biology from UC Berkeley in 2017, where he worked in the Doudna Lab and Savage Lab, UC Berkeley Associate Professor of...

Cortera Neurotechnologies

Brief Description

Cortera Neurotechnologies, Inc. designs medical devices aimed at revolutionizing the treatment of incurable neurological conditions. The company's mission was to deliver innovative products that improve patient care, quality of life and advance neuroscientific research.

Rikky Muller (PhD ’13 EECS) invented the company's foundational technology, a micro-electrocorticography (ECoG) device, as a PhD student in electrical engineering and computer sciences at UC Berkeley. The small implant — as thin as plastic wrap and as flexible as a soft contact lens — can record...

Iaterion

Brief Description

Iaterion is a biopharma company developing novel therapeutics for women's health and diseases. The company develops targeted selective nuclear receptor drugs addressing multiple indications encountered by women and focuses on novel drugs as an alternative to menopausal hormone therapy (MHT). The company was founded to commercialize a novel discovery made by UC Berkeley Adjunct Professor in the Department of Nutritional Sciences Dale Leitman, MD, PhD, for nuclear receptors reprogramming (NRRP) agents.

Iaterion's team brings decades of experience in the bio-...

GenEdit, Inc.

Brief Description

GenEdit develops innovative therapies through targeted delivery of genetic medicines. The GenEdit founders share the vision that recent scientific advancements in engineering CRISPR components and delivery vehicles offer a groundbreaking opportunity to develop safe and effective medicines for genetic diseases.

The company's proprietary Polymer nanoparticle can deliver CRISPR protein and gRNA. CRISPR in a protein form has many advantages, delivery has been a challenge limiting its application. To deliver CRISPR protein, encapsulation of CRISPR ribonucleoprotein (RNP...

Enable Biosciences, Inc.

Brief Description

Enable Biosciences is an early-stage biotech company creating the next generation of tools for predictive medicine, with diagnostics 10,000x more sensitive than previous methods, for earlier detection and treatment of diseases like HIV and type 1 diabetes.

The company was co-founded by UC Berkeley Professor of Chemistry Carolyn Bertozzi, with Drs. Peter Robinson and Jason Tsai, who were PhD students in her lab. In 2022, Dr. Bertozzi shared the Nobel Prize in Chemistry for taking click chemistry, which allows molecules to snap together in a quick and efficient way,...

Q-Chem Inc.

Brief Description

Q-Chem, Inc. is a comprehensive ab initio quantum chemistry program to solve computational problems faster, more accurately and less expensively than ever before possible. Q-Chem's capabilities facilitate applications in pharmaceuticals, materials science, biochemistry, and other fields. Q-Chem also provides users with the highest level of technical support.

Timeline 1993. Company founded 1997. Product in market Inventors

Alex Sodt, Andreas Dreuw, Anna Krylov, Anthony Dutoi, Barry Dunietz, Brian Austin, Chao Ping Hsu; Charles...

Protiveris, Inc.

Brief Description

Protiveris Inc. develops and commercializes micro- and nanocantilever systems for academic research, drug discovery and development, bio-defense, protein research, and discovery of new pharmaceuticals and diagnostic applications.

Timeline 1998. Company founded Inventors

Ohmyyoung Kwon, Arunava Majumdar, Minyao Mao, Thomas Perazzo, Guanghua Wu, Yang Zhao

Omniox, Inc.

Brief Description

Omniox is an early stage biopharmaceutical company developing new medicines for hypoxic diseases. Hypoxia (oxygen deficiency) impacts cancer, cardiovascular diseases, trauma and many other conditions. The company has engineered an unusually stable oxygen carrier technology (H-NOX) to deliver oxygen into hypoxic tissues and improve the treatment of severe unmet medical needs. The technology overcomes the modes of failure of prior efforts in the field of oxygen therapeutics.

Timeline 2006. Company founded. Inventors

Elizabeth Boon,...

Nodexus, Inc.

Brief Description

Nodexus is commercializing an integrated, “one-click” platform that is low-cost, compact, and provides a simplified workflow to deliver enriched single cells of interest from a wide variety of samples such as stem cells, transfected cell lines, cultured cell lines, dissociated tissue, and whole blood.

Timeline 2014. Company founded. Inventors

Lydia Sohn, Daniel Yang, George Anwar, James Hack, Karthik Balakrishnan, Matthew Chambers, Matthew Chapman

Magnetic Tides

Brief Description

Magnetic Tides has developed a new non-invasive brain stimulation (NIBS) system capable of modulating brain function more reliably and effectively than previously existing NIBS methods.

NIBS is used as a research tool to safely, transiently alter the excitability state of targeted neurons when testing causal hypotheses about brain-behavior relationships. In addition, clinicians have recognized the potential of NIBS as a new intervention in the treatment of neurological and psychiatric disorders.

Timeline 2019. Company founded Inventors

...